Duprey Lauren Rusckowski — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Duprey Lauren Rusckowski has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Duprey Lauren Rusckowski

Lauren Rusckowski Duprey is an executive in the pharmaceutical industry, currently serving as the Chief Transformation Officer at Takeda Pharmaceutical Co. Ltd. Her role involves overseeing significant changes and improvements within the company to enhance its operational efficiency and strategic direction.

RoleChief Transformation Officer
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06TAKTAKEDA PHARMACEUTICAL CO LTDA — Grant or award45.1K$0.00
2026-04-28TAKTAKEDA PHARMACEUTICAL CO LTDA — Grant or award60.0K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Duprey Lauren Rusckowski?

Lauren Rusckowski Duprey is an executive in the pharmaceutical industry, currently serving as the Chief Transformation Officer at Takeda Pharmaceutical Co. Ltd. Her role involves overseeing significant changes and improvements within the company to enhance its operational efficiency and strategic direction.…

How many SEC Form 4 filings has Duprey Lauren Rusckowski submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Duprey Lauren Rusckowski's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Duprey Lauren Rusckowski profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.